Pfizer initiates phase III of influenza vaccine candidate
![Photo: Peter Nicholls/REUTERS / X03508](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14404355.ece/ALTERNATES/schema-16_9/doc7mqth1izu2083jcp1zo.jpg)
US-based pharmaceutical firm Pfizer has initiated a larger phase III trial of a new influenza vaccine candidate, which has the potential to be even better than existing vaccines on the marker, the company announces in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Moderna says it’s suing Pfizer, Biontech over Covid-19 shots
For subscribers